156 related articles for article (PubMed ID: 37258577)
1. TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1.
Fei X; Dou YN; Sun K; Wei J; Guo Q; Wang L; Wu X; Lv W; Jiang X; Fei Z
Exp Mol Med; 2023 Jun; 55(6):1203-1217. PubMed ID: 37258577
[TBL] [Abstract][Full Text] [Related]
2. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
[TBL] [Abstract][Full Text] [Related]
3. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract][Full Text] [Related]
4. Aberrant KAT2A accumulations render TRIM22-low melanoma sensitive to Notch1 inhibitors via epigenetic reprogramming.
Gu X; Min W; Zeng Y; Fan N; Qian Q
J Transl Med; 2023 Jul; 21(1):443. PubMed ID: 37415153
[TBL] [Abstract][Full Text] [Related]
5. Identification of TRIM22 as a RING finger E3 ubiquitin ligase.
Duan Z; Gao B; Xu W; Xiong S
Biochem Biophys Res Commun; 2008 Sep; 374(3):502-6. PubMed ID: 18656448
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Tripartite motif-containing 22 (TRIM22)relieved the apoptosis of lens epithelial cells by suppressing the expression of TNF receptor-associated factor 6 (TRAF6).
Meng K; Fang C
Bioengineered; 2021 Dec; 12(1):7213-7222. PubMed ID: 34558381
[TBL] [Abstract][Full Text] [Related]
7. Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator.
Yu S; Gao B; Duan Z; Xu W; Xiong S
Biochem Biophys Res Commun; 2011 Jul; 410(2):247-51. PubMed ID: 21651891
[TBL] [Abstract][Full Text] [Related]
8. TRIM22 orchestrates the proliferation of GBMs and the benefits of TMZ by coordinating the modification and degradation of RIG-I.
Fei X; Wu X; Dou YN; Sun K; Guo Q; Zhang L; Li S; Wei J; Huan Y; He X; Fei Z
Mol Ther Oncolytics; 2022 Sep; 26():413-428. PubMed ID: 36159777
[TBL] [Abstract][Full Text] [Related]
9. Induction of TRIM22 by IFN-γ Involves JAK and PC-PLC/PKC, but Not MAPKs and pI3K/Akt/mTOR Pathways.
Gao B; Xu W; Wang Y; Zhong L; Xiong S
J Interferon Cytokine Res; 2013 Oct; 33(10):578-87. PubMed ID: 23659673
[TBL] [Abstract][Full Text] [Related]
10. FOXC1‑mediated TRIM22 regulates the excessive proliferation and inflammation of fibroblast‑like synoviocytes in rheumatoid arthritis via NF‑κB signaling pathway.
Wei Y; Huang X; Ma Y; Dai L
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35946462
[TBL] [Abstract][Full Text] [Related]
11. TRIM22 inhibits the TRAF6-stimulated NF-κB pathway by targeting TAB2 for degradation.
Qiu H; Huang F; Xiao H; Sun B; Yang R
Virol Sin; 2013 Aug; 28(4):209-15. PubMed ID: 23818111
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of TRIM22 Relieves Oxygen-Glucose Deprivation/Reoxygenation-Induced Apoptosis and Inflammation Through Inhibition of NF-κB/NLRP3 Axis.
Kang C; Lu Z; Zhu G; Chen Y; Wu Y
Cell Mol Neurobiol; 2021 Mar; 41(2):341-351. PubMed ID: 32335773
[TBL] [Abstract][Full Text] [Related]
13. TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway.
Li L; Qi Y; Ma X; Xiong G; Wang L; Bao C
Cell Biol Int; 2018 Sep; 42(9):1192-1199. PubMed ID: 29762880
[TBL] [Abstract][Full Text] [Related]
14. Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.
Li Q; Lee CH; Peters LA; Mastropaolo LA; Thoeni C; Elkadri A; Schwerd T; Zhu J; Zhang B; Zhao Y; Hao K; Dinarzo A; Hoffman G; Kidd BA; Murchie R; Al Adham Z; Guo C; Kotlarz D; Cutz E; Walters TD; Shouval DS; Curran M; Dobrin R; Brodmerkel C; Snapper SB; Klein C; Brumell JH; Hu M; Nanan R; Snanter-Nanan B; Wong M; Le Deist F; Haddad E; Roifman CM; Deslandres C; Griffiths AM; Gaskin KJ; Uhlig HH; Schadt EE; Muise AM
Gastroenterology; 2016 May; 150(5):1196-1207. PubMed ID: 26836588
[TBL] [Abstract][Full Text] [Related]
15. miR-215 Enhances HCV Replication by Targeting TRIM22 and Inactivating NF-κB Signaling.
Tian H; He Z
Yonsei Med J; 2018 Jun; 59(4):511-518. PubMed ID: 29749134
[TBL] [Abstract][Full Text] [Related]
16. TRIM22-Mediated Apoptosis is Associated with Bak Oligomerization in Monocytes.
Chen C; Zhao D; Fang S; Chen Q; Cheng B; Fang X; Shu Q
Sci Rep; 2017 Jan; 7():39961. PubMed ID: 28079123
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of autophagy induced by activation of the AMPK/ERK/mTOR signaling pathway after TRIM22-mediated DENV-2 infection of HUVECs.
Wu N; Gou X; Hu P; Chen Y; Ji J; Wang Y; Zuo L
Virol J; 2022 Dec; 19(1):228. PubMed ID: 36587218
[TBL] [Abstract][Full Text] [Related]
18. TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis.
Zhang L; Zhang B; Wei M; Xu Z; Kong W; Deng K; Xu X; Zhang L; Ζhao X; Yan L
Int J Oncol; 2020 May; 56(5):1225-1239. PubMed ID: 32319602
[TBL] [Abstract][Full Text] [Related]
19. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.
Gao B; Duan Z; Xu W; Xiong S
Hepatology; 2009 Aug; 50(2):424-33. PubMed ID: 19585648
[TBL] [Abstract][Full Text] [Related]
20. TRIM22 can activate the noncanonical NF-κB pathway by affecting IKKα.
Qiu H; Huang F; Gong J; Xiao H; Sun BL; Yang RG
J Recept Signal Transduct Res; 2015; 35(4):289-94. PubMed ID: 25510414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
